You Position: Home > Paper
Protective effect of pantoprazole on gastric mucosal lesions in rats and its mechanism
( views:191, downloads:0 )
- Author:
- No author available
- Journal Title:
- WORLD CHINESE JOURNAL OF DIGESTOLOGY
- Issue:
- 20
- DOI:
- 10.3969/j.issn.1009-3079.2005.20.017
- Key Word:
- 潘托拉唑;胃黏膜损伤;细胞保护;一氧化氮
Abstract： 目的:探讨潘托拉唑对大鼠胃黏膜损伤保护的作用及其机制.方法:在乙醇诱导大鼠胃黏膜损伤前,预先给予(iv)潘托拉唑(20 mg/kg)、L-硝基-精氨酸甲酯(L-NAME,4 mg/kg)及L-精氨酸(250 mg/kg).采用激光多普勒血流计(LDF)测定胃黏膜血流量(GMBF),采用镉粒还原和比色法测定胃黏膜和血浆NO-2/NO-3含量,并观察了胃黏膜损伤指数(ulcer index,UI)、溃疡坏死组织和中性粒细胞浸润严重程度的变化.结果:与模型损伤组比,潘托拉唑组大鼠UI明显降低(5.7±2.1 vs 25.4±2.5,P＜0.01),溃疡坏死组织和中性粒细胞浸润程度明显减轻.预先用L-NAME处理后,潘托拉唑保护胃黏膜损伤作用明显减弱;L-NAME抑制作用可被L-精氨酸拮抗.iv潘托拉唑,可增加GMBF、胃黏膜和血浆NO-2/NO-3,L-NAME可逆转这种作用,但对潘托拉唑抑制酸分泌作用无明显影响.结论:潘托拉唑通过一氧化氮介导对大鼠胃黏膜损伤有重要的保护作用,而与潘托拉唑抑制酸分泌作用无关.
- [1]Joshua Ka-Shun Ko,Chi-Hin Cho,Shiu-Kum Lam.Adaptive cytoprotection through modulation of nitric oxide in ethanol-evoked gastritis[J].2004,(17).
- [2]乐桥良,文晓冬.大鼠应激性溃疡中一氧化氮的作用[J].2000,(7).
- [3]乐桥良,张捷,许其增,等.一氧化氮和前列腺素在门静脉高压性胃病大鼠胃粘膜灌注中的作用[J].2001,(4).
- [4]Becker A,Sander P,Lucker PW,etc.Pharmacodynamic effects of 3-day intravenous treatment with pantoprazole or ranitidine after 10 days of oral ranitidine.[J].2005,27(1).
- [5]G, Bianchi Porro,M, Lazzaroni,V, Imbesi,etc.Efficacy of pantoprazole in the prevention of peptic ulcers, induced by non-steroidal anti-inflammatory drugs: a prospective, placebo-controlled, double-blind, parallel-group study.[J].2000,32(3).
- [6]Shah PJ,Gandhi MS,Shah MB,etc.Study of Mimusops elengi bark in experimental gastric ulcers.[J].2003,89(2/3).
- [7]Natale G,Colucci R,Blandizzi C,etc.Gastroprotective effects of pantoprazole against experimental mucosal damage.[J].2000,14(2).
- [8]Shoda R,Muraoka A,Yamato S,etc.Nitric oxide donating compounds inhibit HCl-induced gastric mucosal lesions mainly via prostaglandin.[J].2001,85(2).
- [9]Sachs G.Physiology of the parietal cell and therapeutic implications.[J].2003,23(10 Pt.2).
- [10]Morris P,Polak JM,Schaefer Preuss S,etc.Pantoprazole in severe acid-peptic disease: the effectiveness and safety of 5 years' continuous treatment.[J].2005,37(1).
- [11]Brown NJ,Jacob S,Reed MW,etc.L-Arginine protects and exacerbates ethanol-induced rat gastric mucosal injury.[J].2000,15(8).
- [12]Motilva V,Herrerias JM,Ortiz P,etc.Role of prostaglandins and nitric oxide in gastric damage induced by metamizol in rats.[J].2002,51(8).
- [13]Lehmann FS,Beglinger C.Role of pantoprazole in the treatment of gastro-oesophageal reflux disease.[J].2005,6(1).
- [14]Ohta Y,Nishida K.Protective effect of L-arginine against stress-induced gastric mucosal lesions in rats and its relation to nitric oxide-mediated inhibition of neutrophil infiltration.[J].2001,43(6).
- [15]Spirt MJ.Stress-related mucosal disease: risk factors and prophylactic therapy.[J].2004,26(2).
- [16]Samini M,Jabarizadeh N,Shafaroodi H,etc.Evidences for involvement of nitric oxide in the gastroprotective effect of bromocriptine and cyclosporin A on water immersion stress-induced gastric lesions.[J].2002,46(6).
- [17]Metz DC.Preventing the gastrointestinal consequences of stress-related mucosal disease.[J].2005,21(1).
- [18]M, Lazzaroni,G, Bianchi Porro.Non-steroidal anti-inflammatory drug gastropathy: clinical results with H2 antagonists and proton pump inhibitors.[J].1999,31 Suppl 1.